• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

等张/低张生理盐水作为 5 岁以下儿童普通儿科病房维持静脉补液治疗的随机对照试验。

Isotonic hypotonic saline as maintenance intravenous fluid therapy in children under 5 years of age admitted to general paediatric wards: a randomised controlled trial.

机构信息

Department of Paediatrics, Chacha Nehru Bal Chikitsalaya, New Delhi, India.

出版信息

Paediatr Int Child Health. 2020 Feb;40(1):44-49. doi: 10.1080/20469047.2019.1619059. Epub 2019 May 29.

DOI:10.1080/20469047.2019.1619059
PMID:31138063
Abstract

: To prevent the risk of iatrogenic hyponatraemia in hospitalised children, isotonic fluid has been recommended as maintenance intravenous fluid (IVF). There are few studies which compare half normal saline with normal saline as maintenance IVF in general paediatric wards.: To compare the safety and efficacy of half normal saline with normal saline as maintenance IVF in general paediatric wards.: Children aged between 3 months and 5 years with an anticipated requirement for IVF for 24 h were randomised to receive either half normal saline (0.45% saline in 5% dextrose) or normal saline (0.9% saline in 5% dextrose). The primary objective was to compare the incidence of hyponatraemia (serum sodium <135 mmol/L with a decrease from baseline of at least 4 mmol/L) at 24 h in children receiving half normal saline with those receiving normal saline. Secondary objectives were to compare the incidence of moderate (sodium <130 mmol/L), severe (sodium <125 mmol/L) and symptomatic hyponatraemia, change in serum sodium level from baseline and the incidence of hypernatraemia.: A total of 168 children were randomised to receive either normal saline ( = 84) or half normal saline ( = 84). More than two-thirds of the children were suffering from respiratory diseases (pneumonia and bronchiolitis) and diseases of the nervous system (meningoencephalitis, febrile seizures and epilepsy). The incidence of hyponatraemia at 12 h in children receiving half normal saline was similar to that in those receiving normal saline (6 4.8%; Relative risk (RR) 1.2; 95% CI 0.3.0-4.8; = 0.73). Although the incidence of hyponatraemia at 24 h in children receiving half normal saline was higher than in those receiving normal saline, the difference was not statistically significant (14.3 6%; RR 2.6; 95% CI 0.9-7.8; = 0.07). One child in the isotonic group and one in the hypotonic group developed moderate and severe hyponatraemia, respectively. There was no significant difference in the incidence of hypernatraemia between two groups (RR 0.7; 95% CI 0.16-3.3).: Half-normal saline as maintenance IVF does not result in a significantly increased risk of hyponatraemia in general paediatric ward patients under 5 years of age.

摘要

在住院的儿童中,为了预防医源性低钠血症的风险,已推荐使用等渗液作为维持性静脉输液(IVF)。很少有研究比较半生理盐水与生理盐水作为普通儿科病房的维持性 IVF。

目的

比较半生理盐水与生理盐水作为普通儿科病房维持性 IVF 的安全性和疗效。

方法

将年龄在 3 个月至 5 岁之间、预计需要 24 小时 IVF 的儿童随机分为半生理盐水(5%葡萄糖中的 0.45%盐水)或生理盐水(5%葡萄糖中的 0.9%盐水)组。主要目的是比较接受半生理盐水治疗的儿童与接受生理盐水治疗的儿童在 24 小时时低钠血症(血清钠 <135mmol/L,与基线相比至少下降 4mmol/L)的发生率。次要目标是比较中度(血清钠 <130mmol/L)、重度(血清钠 <125mmol/L)和有症状性低钠血症的发生率、血清钠水平从基线的变化以及高钠血症的发生率。

结果

共 168 名儿童被随机分为生理盐水组(n=84)或半生理盐水组(n=84)。超过三分之二的儿童患有呼吸系统疾病(肺炎和细支气管炎)和神经系统疾病(脑膜炎、热性惊厥和癫痫)。接受半生理盐水治疗的儿童在 12 小时时低钠血症的发生率与接受生理盐水治疗的儿童相似(6 4.8%;相对风险(RR)1.2;95%CI 0.3-4.8; = 0.73)。尽管接受半生理盐水治疗的儿童在 24 小时时低钠血症的发生率高于接受生理盐水治疗的儿童,但差异无统计学意义(14.3 6%;RR 2.6;95%CI 0.9-7.8; = 0.07)。等渗组和低渗组各有 1 例儿童出现中度和重度低钠血症。两组高钠血症的发生率无显著差异(RR 0.7;95%CI 0.16-3.3)。

结论

在 5 岁以下普通儿科病房患者中,半生理盐水作为维持性 IVF 不会显著增加低钠血症的风险。

相似文献

1
Isotonic hypotonic saline as maintenance intravenous fluid therapy in children under 5 years of age admitted to general paediatric wards: a randomised controlled trial.等张/低张生理盐水作为 5 岁以下儿童普通儿科病房维持静脉补液治疗的随机对照试验。
Paediatr Int Child Health. 2020 Feb;40(1):44-49. doi: 10.1080/20469047.2019.1619059. Epub 2019 May 29.
2
A prospective trial comparing isotonic with hypotonic maintenance fluids for prevention of hospital-acquired hyponatraemia.一项比较等渗与低渗维持液预防医院获得性低钠血症的前瞻性试验。
Paediatr Int Child Health. 2016 Aug;36(3):168-74. doi: 10.1179/2046905515Y.0000000047.
3
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children.等渗溶液与低渗溶液用于儿童维持性静脉输液
Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD009457. doi: 10.1002/14651858.CD009457.pub2.
4
Incidence of hyponatraemia following the use of three different intravenous fluids in paediatric surgery.小儿外科中使用三种不同静脉输液后低钠血症的发生率。
Afr J Paediatr Surg. 2018 Apr-Jun;15(2):69-72. doi: 10.4103/ajps.AJPS_40_16.
5
Isotonic versus hypotonic saline solution for maintenance intravenous fluid therapy in children: a systematic review.等渗与低渗盐溶液用于儿童维持性静脉输液治疗:一项系统评价
Pediatr Nephrol. 2015 Jul;30(7):1163-72. doi: 10.1007/s00467-014-3033-y. Epub 2015 Jan 11.
6
140 mmol/L of sodium versus 77 mmol/L of sodium in maintenance intravenous fluid therapy for children in hospital (PIMS): a randomised controlled double-blind trial.维持性静脉输液治疗住院儿童中 140mmol/L 与 77mmol/L 钠的比较(PIMS):一项随机对照双盲试验。
Lancet. 2015 Mar 28;385(9974):1190-7. doi: 10.1016/S0140-6736(14)61459-8. Epub 2014 Dec 1.
7
Isotonic is better than hypotonic saline for intravenous rehydration of children with gastroenteritis: a prospective randomised study.等渗溶液在小儿胃肠炎静脉补液中优于低渗盐水:一项前瞻性随机研究。
Arch Dis Child. 2006 Mar;91(3):226-32. doi: 10.1136/adc.2005.084103. Epub 2005 Dec 13.
8
Hyponatraemia despite isotonic maintenance fluid therapy: a time series intervention study.尽管使用等渗维持液治疗,仍出现低钠血症:一项时间序列干预研究。
Arch Dis Child. 2021 Apr 21;106(5):491-495. doi: 10.1136/archdischild-2019-318555.
9
0.45% Versus 0.9% Saline in 5% Dextrose as Maintenance Fluids in Children Admitted With Acute Illness: A Randomized Control Trial.0.45% 盐水与 0.9% 生理盐水在 5% 葡萄糖中作为急性疾病入院儿童的维持液:一项随机对照试验。
Pediatr Emerg Care. 2022 Sep 1;38(9):436-441. doi: 10.1097/PEC.0000000000002621. Epub 2022 Jan 26.
10
Isotonic versus Hypotonic Intravenous Maintenance Fluids in Children: A Randomized Controlled Trial.等张与低张静脉维持液在儿童中的应用:一项随机对照试验。
Indian J Pediatr. 2019 Nov;86(11):1011-1016. doi: 10.1007/s12098-019-03011-5. Epub 2019 Jul 6.

引用本文的文献

1
Efficacy and safety of isotonic versus hypotonic intravenous maintenance fluids in hospitalized children: an updated systematic review and meta-analysis of randomized controlled trials.等渗与低渗静脉维持液在住院儿童中的疗效和安全性:一项更新的系统评价和随机对照试验荟萃分析。
Pediatr Nephrol. 2024 Jan;39(1):57-84. doi: 10.1007/s00467-023-06032-7. Epub 2023 Jun 26.
2
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of Hyponatremia.韩国肾脏病学会2022年低钠血症诊断和管理争议问题推荐意见
Electrolyte Blood Press. 2022 Jun;20(1):21-38. doi: 10.5049/EBP.2022.20.1.21. Epub 2022 Jun 30.
3
ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysis.
ESPNIC 临床实践指南:急性和危重症儿童的静脉维持液疗法——系统评价和荟萃分析。
Intensive Care Med. 2022 Dec;48(12):1691-1708. doi: 10.1007/s00134-022-06882-z. Epub 2022 Oct 26.
4
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia.韩国肾脏病学会 2022 年关于低钠血症诊断和管理中争议问题的建议。
Korean J Intern Med. 2022 Nov;37(6):1120-1137. doi: 10.3904/kjim.2022.174. Epub 2022 Oct 17.
5
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia.韩国肾脏病学会2022年低钠血症诊断和管理争议问题指南
Kidney Res Clin Pract. 2022 Jul;41(4):393-411. doi: 10.23876/j.krcp.33.555. Epub 2022 Jul 28.
6
Efficacy and Safety of Isotonic and Hypotonic Intravenous Maintenance Fluids in Hospitalised Children: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.等渗和低渗静脉维持液在住院儿童中的疗效和安全性:随机对照试验的系统评价和荟萃分析
Children (Basel). 2021 Sep 8;8(9):785. doi: 10.3390/children8090785.
7
Fluid Rate Is Important As Much As Fluid Tonicity: An Experimental Study.液体速率与液体张力同样重要:一项实验研究
Eurasian J Med. 2021 Jun;53(2):118-122. doi: 10.5152/eurasianjmed.2021.20276.